Description

KPV — Alpha-MSH C-Terminal Tripeptide

KPV is a synthetic tripeptide representing the C-terminal sequence of alpha-Melanocyte Stimulating Hormone (α-MSH). It has been studied in preclinical models for anti-inflammatory activity in gastrointestinal and skin tissue, with research examining its interaction with melanocortin receptors MC1R and MC3R independent of the full α-MSH sequence. KPV is frequently studied in the context of inflammatory bowel disease models and skin inflammation research.

Specifications

• CAS Number: 67727-97-3
• Molecular Weight: 342.43 Da
• Sequence: Lys-Pro-Val
• Amino Acids: 3
• Form: Lyophilized Powder
• Purity: ≥99% — Vanguard Laboratory Verified
• Storage: -20°C Lyophilized / 4°C Reconstituted
• Volume: 3ml

Testing and Verification

Every batch independently tested by Vanguard Laboratory — ISO/IEC 17025:2017 accredited, A2LA Certificate #6377.01.

For Research Use Only — Not For Human Consumption. This product is intended exclusively for laboratory and in-vitro scientific research purposes. It has not been evaluated by the FDA for safety or efficacy in humans or animals.